X

Xencor
D

XNCR

20.690
USD
0.25
(1.22%)
Market Closed
Volume
16,419
EPS
-1
Div Yield
-
P/E
-6
Market Cap
1,447,928,201
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    B
    BMRN
    -0.463
    (-0.74%)
    62.027 USD
    C
    CLDT
    -0.07000
    (-0.80%)
    8.72000 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    ILMN
    ILMN
    -1.005
    (-0.71%)
    140.300 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    T
    TGTX
    -0.690
    (-2.31%)
    29.150 USD
    More
News

Title: Xencor

Sector: Healthcare
Industry: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.